You just read:

Theravance Biopharma Receives FDA Fast Track Designation for Velusetrag (TD-5108) for Idiopathic and Diabetic Gastroparesis

News provided by

Theravance Biopharma, Inc.

06 Dec, 2016, 08:30 ET